Author | Lyudmila A. Bazhenova, MD


Dr. Bazhenova on Considering Factors to Treat Non-Driver Patients With NSCLC With Bevacizumab

September 01, 2017

Lyudmila A. Bazhenova, MD, medical oncologist, professor of medicine, UC San Diego Health, discusses the factors to take into consideration when treating a patient with non-driver non–small cell lung cancer with bevacizumab (Avastin).